Patent details

Basic Information

Publication number:

EP2809321

PCT Application Number:

PCT/EP/2013/051871

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137022190

PCT Publication Number:

WO/2013/113799

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHENYL-C-OXADIAZOLE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE PRODUCTION FOR USE IN COMBINATION THERAPY

French Title of Invention:

DÉRIVÉS DE PHÉNYL-C-OXADIAZOLE COMME INHIBITEURS DE LA PRODUCTION DE LEUCOTRIÈNES POUR LEUR UTILISATION DANS UN TRAITEMENT COMBINÉ

German Title of Invention:

PHENYL-C-OXADIAZOL-DERIVATE ALS INHIBITOREN DER LEUKOTRIENPRODUKTION ZUR VERWENDUNG IN EINER KOMBINATIONSTHERAPIE

SPC Number:

Dates

Filing date:

31/01/2013

Grant date:

09/11/2016

EP Publication Date:

09/11/2016

PCT Publication Date:

08/08/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/12/2014

EP B1 Publication Date:

09/11/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/01/2017

Expiration date:

31/01/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/01/2013

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

Name:

BYLOCK Lars Anders

Address:

Germany (DE)

Priority

Priority Number:

201261593638

Priority Date:

01/02/2012

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4245;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages